Banxia Xiexin Decoction Alleviated Cerebral Glucose Metabolism Disorder by Regulating Intestinal Microbiota in APP/PS1 Mice.

Gao, Chen-Yan; Qin, Gao-Feng; Zheng, Ming-Cui; Tian, Mei-Jing; He, Yan-Nan; Wang, Peng-Wen.

Afiliação

Gao CY; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Qin GF; Neurology Department, Binzhou Medical University Hospital, Binzhou, Shandong Province, 256603, China.
Zheng MC; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Tian MJ; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
He YN; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Wang PW; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China. pw_wang@163.com.

Chin J Integr Med ; 2023 Nov 21.

Article em En | MEDLINE | ID: mdl-37987962

Palavras-chave

Alzheimer's disease; Banxia Xiexin Decoction; Chinese medicine; cerebral insulin resistance; glucagon-like peptide 1; intestinal microbiota; phosphoinositide-3-kinase/protein kinase B/glycogen synthase kinase-3ß

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article